Metraipolis › archive › dc_016ad440f199
The Use of Single Dose of Rasburicase for the Prophylaxis and Treatment of Tumor Lysis Syndrome in Pediatric Patients: A Narrative Review — Europe PMC PMID:41440769
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41440769
- DOI
- 10.3390/hematolrep17060071
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:34:42.120Z
- SHA-256 of the archived text
91ae754a1e1ba3775482b69ccdcca07a3b427c98e42cd8fe6c1537f6554862fe- Stable URL of this page
https://metraipolis.com/documento/dc_016ad440f199
How to cite
The Use of Single Dose of Rasburicase for the Prophylaxis and Treatment of Tumor Lysis Syndrome in Pediatric Patients: A Narrative Review — Europe PMC PMID:41440769 — Europe PMC (en), https://europepmc.org/article/MED/41440769 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_016ad440f199 (Metraipolis archive dc_016ad440f199, sha256 91ae754a1e1ba3775482b69ccdcca07a3b427c98e42cd8fe6c1537f6554862fe)
BibTeX
@misc{dc016ad440f199,
title = {The Use of Single Dose of Rasburicase for the Prophylaxis and Treatment of Tumor Lysis Syndrome in Pediatric Patients: A Narrative Review — Europe PMC PMID:41440769},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41440769},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_016ad440f199; sha256 91ae754a1e1ba3775482b69ccdcca07a3b427c98e42cd8fe6c1537f6554862fe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41440769. Agents can read the archived copy with the MCP tool read_document.